El Paso, NM
Chelation Therapy clinics in El Paso
Chelation therapy in El Paso is offered by a small set of integrative and naturopathic clinics, typically for documented heavy metal toxicity confirmed by provocation or baseline testing. Common agents include calcium disodium EDTA, DMPS, DMSA, and deferoxamine, each with specific binding profiles for lead, mercury, arsenic, or iron.
Most El Paso chelation providers are MDs or DOs with ACAM training, and in some states naturopathic doctors within their licensed scope. Protocols vary from 10-session courses for basic detoxification to longer 30-session cardiovascular protocols modeled on the TACT trial. Pricing is cash-pay in almost every case, and no insurance covers off-label chelation.
With verified chelation therapy clinics on Regenerated.com in El Paso, Texas, patients can compare provider credentials, testing protocols, and agent selection. Regenerated.com does not recommend chelation for cardiovascular disease or autism. The FDA has only approved specific agents for specific heavy metal poisoning diagnoses. Chelation outside that narrow indication is off-label, and in the wrong hands it has caused deaths.
No clinics found
Reset all filtersRegulatory context
A note on New Mexico's chelation therapy rules.
The FDA has approved a narrow set of chelating agents for specific heavy metal toxicities. Calcium disodium edetate (CaNa2EDTA, Versenate) is approved for symptomatic lead poisoning, succimer (Chemet, DMSA) for pediatric lead poisoning at blood lead levels above 45 mcg/dL, deferoxamine (Desferal) and deferasirox (Exjade) for chronic iron overload, and dimercaprol (BAL) for arsenic, gold, and acute lead poisoning. Use of EDTA chelation for cardiovascular disease was studied in the NIH-funded TACT trial (2013) with controversial findings and remains not FDA-approved for that indication. Chelation for autism spectrum disorder is not evidence-based and has been linked to pediatric deaths. The FDA issued a 2010 sweep of warning letters to compounders marketing OTC chelation products with unapproved disease claims.
-
New Mexico Medical Practice Act, NMSA 1978, Chapter 61, Article 6
Governs MD practice in New Mexico. -
New Mexico Naturopathic Doctor Practice Act, NMSA 1978, Chapter 61, Article 7A
Licenses NDs with a defined scope including some IV therapies.
The New Mexico Medical Board has investigated chelation practitioners for marketing claims tied to autism and cardiovascular disease. New Mexico is one of the broader-scope ND states. The state has an active integrative medicine community in Santa Fe and Albuquerque. The 2005 Pittsburgh pediatric chelation death informs board expectations for pediatric protocols and use of the correct EDTA salt.
Chelation Therapy in El Paso, answered.
Explore related care